Isotretinoin: reasserting its public health value at the population level, addressing potential neuropsychiatric risk at the individual level.
Saved in:
| Title: | Isotretinoin: reasserting its public health value at the population level, addressing potential neuropsychiatric risk at the individual level. |
|---|---|
| Authors: | Chosidow O; AP-HP, Henri Mondor Hospital, Department of Dermatology - Research Group Dynamic, EA7380, Faculté de Santé de Créteil, Ecole Nationale Vétérinaire d'Alfort, USC ANSES, Paris-Est University, 94010, Créteil, France., Beylot-Barry M; University Hospital of Bordeaux, Department of Dermatology, Bordeaux Institute of Oncology, UMR 1312 INSERM/University of Bordeaux, 33000, Bordeaux, France., Corgibet F; Dermatologic Office, 21000, Dijon, France., Jouan N; Dermatologic Office, 29200, Brest, France., Dupin N; Department of Dermatology, Cochin Hospital, AP-HP, Centre-Université Paris Cité, Paris, France., Guillot B; Université de Montpellier, Montpellier, France. |
| Corporate Authors: | Centre of Evidence of the French Society of Dermatology |
| Source: | The British journal of dermatology [Br J Dermatol] 2022 Nov; Vol. 187 (5), pp. 831-832. Date of Electronic Publication: 2022 Jul 31. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
